LOMUSTINE vs TEMODAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. LOMUSTINE and TEMODAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LOMUSTINE	TEMODAR
Rating	New	70/100
Pharmacy pays	—	~$148.82 /30
Type	RX	RX
Active ingredient	LOMUSTINE	TEMOZOLOMIDE
Manufacturer	Carnegie	Merck Sharp Dohme
Dosage forms	Capsule	Capsule, Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	Boxed warning	None
Half-life	about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug	—
Treats	Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease	Glioblastoma, Melanoma

lomustine temodar

Rating

New

70/100

Pharmacy pays

—

~$148.82 /30

Type

Active ingredient

LOMUSTINE

TEMOZOLOMIDE

Manufacturer

Carnegie

Merck Sharp Dohme

Dosage forms

Capsule

Capsule, Injectable

Drug class

Alkylating Drug

Boxed warning

None

Half-life

about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug

—

Treats

Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease

Glioblastoma, Melanoma

Frequently asked questions

What is the difference between Lomustine and Temodar?

Lomustine contains Lomustine, while Temodar contains Temozolomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.